The state of the art of theranostic nanomaterials for lung, breast, and prostate cancers
Carregando...
Data
Data de publicação
Orientador
Título da Revista
ISSN da Revista
Título do Volume
É parte de
É parte de
É parte de
Nanomaterials
ODS
Exportar
Resumo
The synthesis and engineering of nanomaterials offer more robust systems for the
treatment of cancer, with technologies that combine therapy with imaging diagnostic tools in the
so‐called nanotheranostics. Among the most studied systems, there are quantum dots, liposomes,
polymeric nanoparticles, inorganic nanoparticles, magnetic nanoparticles, dendrimers, and gold
nanoparticles. Most of the advantages of nanomaterials over the classic anticancer therapies come
from their optimal size, which prevents the elimination by the kidneys and enhances their
permeation in the tumor due to the abnormal blood vessels present in cancer tissues. Furthermore,
the drug delivery and the contrast efficiency for imaging are enhanced, especially due to the
increased surface area and the selective accumulation in the desired tissues. This property leads to
the reduced drug dose necessary to exert the desired effect and for a longer action within the tumor.
Finally, they are made so that there is no degradation into toxic byproducts and have a lower
immune response triggering. In this article, we intend to review and discuss the state‐of‐the‐art
regarding the use of nanomaterials as therapeutic and diagnostic tools for lung, breast, and prostate
cancer, as they are among the most prevalent worldwide.
Como referenciar
FREITAS, LUCAS F.; FERREIRA, ARYEL H.; THIPE, VELAPHI C.; VARCA, GUSTAVO H.C.; LIMA, CAROLINE S.A.; BATISTA, JORGE G.S.; RIELLO, FABIANE N.; NOGUEIRA, KAMILA; CRUZ, CASSIA P.C.; MENDES, GIOVANNA O.A.; RODRIGUES, ADRIANA S.; SOUSA, THAYNA S.; ALVES, VICTORIA M.; LUGAO, ADEMAR B. The state of the art of theranostic nanomaterials for lung, breast, and prostate cancers. Nanomaterials, v. 11, n. 10, p. 1-31, 2021. DOI: 10.3390/nano11102579. Disponível em: http://repositorio.ipen.br/handle/123456789/32305. Acesso em: 30 Dec 2025.
Esta referência é gerada automaticamente de acordo com as normas do estilo IPEN/SP (ABNT NBR 6023) e recomenda-se uma verificação final e ajustes caso necessário.